Approval · Notice of Compliance 10180 · 2009
AZITHROMYCIN FOR INJECTION: Notice of Compliance 10180
Issued April 29, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10180
- Date
- April 29, 2009
- Company
- Novopharm LimitedMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic
- Canadian reference product
- ZITHROMAX (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZITHROMYCIN FOR INJECTION | 02297566 | Cancelled Post Market |
Medicinal ingredients
- AZITHROMYCIN HYDROGEN CITRATE 500 MG per VIAL